Company: HEOR, AbbVie
Job title: VP
Dr. Hebden joined Abbvie in 2013 as Vice President of Global Health Economics and Outcomes Research. As a senior leader at Abbvie, he sits on a number of key decision making bodies responsible for defining the current and future direction of the company.
Prior to joining Abbvie, Tony held several leadership roles at Bristol Myers Squibb in Princeton New Jersey, including Executive Director, Health Economics and Outcomes Research and Global Head of Medical Affairs for Clopidogrel (Plavix).
Dr. Hebden attended The University of London where he received a BSc (Hons) in Physiology and MSc in Applied Physiology, and The University of Nottingham where he received a PhD in Pharmacology. Following this he completed a post-doctoral fellowship at The University of British Columbia, Canada and a second at Tripler Army Medical Center, Hawaii, before taking a faculty position at the University of Ottawa Heart Institute. He has over 100 scientific publications in the areas of cardiovascular and renal physiology and pharmacology as well as Health Economics and Outcomes Research.
Lesson Learned from The Development & Implementation of an Integrated Data & Evidence Strategy at AbbVie 2:15 pm
• Developing and implementing an original data and evidence strategy from first principles – delving into the experience at AbbVie, a new large cap biopharmaceutical company • Exploring the continuous implementation process over the last five years – identifying several key learnings that have led to modifications and additions to the ongoing roll out •…Read more
day: Day One
‘IMPACCT’ Panel Discussion: Value Generation, Real World Evidence & Life Cycle Management – Distilling Strategy for Innovation 9:00 am
• In what stages of the drug life cycle does RWE have greatest impact? • Establishing the right evidence generation plan that meets clinical, regulatory and commercial needs of a product: • How to? • Does it differ between big and small pharma? • What’s the ROI vs. value generation? • Driving internal collaboration for…Read more
day: Day Two